250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Biotechnology Startup Investors in Europe in October 2024

A list of 50 angel investors and VC (Venture Capital) funds that invest in Biotechnology startups based in Europe. We rank investors based on the number of investments they made in Biotechnology companies from Europe. We update this investor list every month.

Top 50 Biotechnology Startup Investors in Europe in October 2024

Investor Biotechnology Europe investments
SOSV 77
Sofinnova Partners 61
UK Innovation & Science Seed Fund 55
Bpifrance 50
Novo Holdings 43
Parkwalk Advisors 43
HTGF | High-Tech Gruenderfonds 42
Oxford Science Enterprises 37
Scottish Enterprise 37
Oxford Technology Management 34
Scottish Investment Bank 33
Kurma Partners 33
Catapult Ventures 31
Enterprise Ireland 30
Oxford Capital 29
Jonathan Milner 29
Boehringer Ingelheim Venture Fund 29
Seventure Partners 29
Oxford Science Enterprises 26
GO CAPITAL 26
Mercia Fund Managers 26
Karista 25
M Ventures 25
BioInnovation Institute 25
Epidarex Capital 25
Centre for the Development of Industrial Technology (CDTI) 23
MIG Capital 22
Development Bank of Wales 22
Auriga Partners 22
Archangels 21
Newable Private Investing 20
Idinvest Partners 20
AlbionVC 20
Omnes Capital 20
Elaia 19
GM&C Life Sciences Fund 19
Future Planet Capital 19
Criteria Venture Tech 19
Deepbridge Capital 19
IP Group 18
Forbion Capital Partners 18
Meusinvest (Noshaq) 18
HealthCap 18
O2h Ventures 18
Octopus Ventures 17
Kelvin Capital 17
Cambridge Angels group 17
AdBio partners 17
TRICAPITAL 16
KfW 16
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
SOSV VC Fund · Princeton, New Jersey, United States · 75 investments in the past 12 months
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Convertible Note, Pre-Seed
  • United States, India, United Kingdom
Portfolio highlights
  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Sofinnova Partners VC Fund · Paris, Ile-de-France, France · 21 investments in the past 12 months
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • deepc — The Radiology AI Platform - Your effortless access to AI
  • Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
  • Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.
UK Innovation & Science Seed Fund VC Fund · Harwell, Oxfordshire, United Kingdom · 12 investments in the past 12 months
UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Funding Round, Series A
  • United Kingdom, United States
Portfolio highlights
  • HonuWorx — HonuWorx is a technology company providing autonomous systems aimed at lowering both expenses and the environmental impact of operating robotic systems. The company's software technology is an edge-cloud architected communications and control platform that enables geographically distributed stakeholders to see data, collaborate, supervise, andcontrol robotic systems that are beyond line-of-sight.
  • Solasta Bio — Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.
  • Wave Photonics — Wave Photonics utilizes computational techniques to accelerate integrated photonics product designs.The company is developing a platform that provides optimized designs and streamlined integration between the supply chain using a software tool for predicting the performance and variation of a component for a given fabrication process and anoptimizer to generate a foundry-specific component library.Wave Photonics is headquartered in Bristol, Bristol.
Bpifrance VC Fund · Maisons-alfort, Ile-de-France, France · 80 investments in the past 12 months
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • France, United States, Switzerland
Portfolio highlights
  • Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
  • Oderis — Oderis helps corporate and private equity clients with transaction advisory, business valuation, consulting and financial assistance.
  • VELA — VELA is an innovative 100% wind-powered maritime transport. It has been working to address the climate emergency by providing a creative, sustainable, and socially responsible maritime transportation solution.
Novo Holdings VC Fund · Hellerup, Hovedstaden, Denmark · 17 investments in the past 12 months
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series A, Series B, Series C
  • United States, Denmark, United Kingdom
Portfolio highlights
  • Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
  • Draupnir Bio — Draupnir Bio is developing new innovative therapies for patients.
  • Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
Parkwalk Advisors VC Fund · London, England, United Kingdom · 14 investments in the past 12 months
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Series A, Series B
  • United Kingdom, United States, Philippines
Portfolio highlights
  • Evoralis — Utilise Our Innovative Enzymes to Efficiently Recycle Plastics Into High-Quality Raw Materials
  • PhoreMost — PhoreMost is a new-model drug discovery company based in Cambridge, UK: Using its core expertise to open up new ‘druggable’ target space and working with a global network of co-invested academic and industrial collaboration partners, we aim to bring a wide array of novel ‘targeted’ therapies more efficiently to market and pass these cost savingsonto patients.
  • OW Smell Made Digital — OW Smell Made Digital offers software and hardware solutions for controlling smell.
HTGF | High-Tech Gruenderfonds VC Fund · Bonn, Nordrhein-Westfalen, Germany · 45 investments in the past 12 months
The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Show more
Investment focus
  • Software, Information Technology, Biotechnology
  • Seed, Series A, Funding Round
  • Germany, Switzerland, United States
Portfolio highlights
  • Samp — Samp accelerates modernization and de-risks contracts by connecting outdated drawings with current 3D reality captures of your facilities using our AI.
  • become.1 — become.1 is an employee benefits platform that eliminates the complexity of tax regulations for employees.
  • Symphera — An all-in-one surgical system that makes minimally-invasive procedures more efficient.
Oxford Science Enterprises VC Fund · Oxford, Oxfordshire, United Kingdom · 7 investments in the past 12 months
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Seed, Series A, Funding Round
  • United Kingdom, United States, Finland
Portfolio highlights
  • FluoRok — By employing our patented technology, we can produce fluorochemicals without the production of toxic and highly dangerous hydrofluoric acid
  • Fractile — Fractile is building chips to run large language models two orders of magnitude faster. Existing hardware is good for training LLMs, but very poorly suited to subsequent inference of the trained model, which is increasingly the dominant workload. A network’s weights need to be moved onto a chip once per word generated, and this movement takes a fewhundred times longer than the subsequent computations themselves. Fractile’s revolutionary approach to fusing computation with memory eliminates this bottleneck, and can scale to allow running the world’s largest models at a global scale.
  • Amber Therapeutics — Developing intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology
Scottish Enterprise VC Fund · Glasgow, Glasgow City, United Kingdom · 24 investments in the past 12 months
Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Grant, Funding Round, Seed
  • United Kingdom, United States, Japan
Portfolio highlights
  • MiAlgae — MiAlgae is a new-age microalgal production company that aims to revolutionize the £340 billion global livestock feed industry by producing microalgal products – through the remediation of wastewater – as nutrient supplements for fishmeal in livestock feeds. Their microalgal products are high in omegas and proteins, both of which are required forthe production of many livestock feeds, especially in the aquaculture sector.Their production methodology uses circular economy to reduce the operating costs involved in the production of microalgae and as such allows them to compete with other supplements currently on the market.
  • Solasta Bio — Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.
  • ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Oxford Technology Management VC Fund · Oxford, Oxfordshire, United Kingdom
Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Funding Round, Series A
  • United Kingdom, United States
Portfolio highlights
  • OxCan — Enabling curative cancer treatment through early detection
  • Metacarpal — Metacarpal design upper-limb prosthetics without compromise. We aim to make the most robust, functional hand prosthesis that people love wearing because it works so effectively and looks so beautiful. Be proud to show your artificial side!
  • MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
Scottish Investment Bank VC Fund · Glasgow, Glasgow City, United Kingdom
Speak with our Entrepreneurship Team, who can help you find sources of finance, engage with funders and secure investment to grow your business.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Funding Round, Seed, Series A
  • United Kingdom, United States, France
Portfolio highlights
  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • IOTech — Discover IOTech Systems, the open edge data platform for developing, deploying, and managing Industrial Edge applications at scale. Find out more here.
  • Administrate — Manage 100% of enterprise training operations with configurable training management software, designed to scale with your organization.
Kurma Partners VC Fund · Paris, Ile-de-France, France · 7 investments in the past 12 months
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more
Investment focus
  • Health Care, Biotechnology, Pharmaceutical
  • Series A, Series B, Seed
  • France, Switzerland, Spain
Portfolio highlights
  • SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
  • PanTera — PanTera wants to bring a new hope to cancer patients by enabling the widespread use of radiopharmaceuticals for personalised treatment of tumors
  • Spotlight Medical — Spotlight Medical is a precision medicine company striving to free all patients from cancer through a better understanding of each patient’s unique disease. We develop advanced AI tests that enhance treatment selection by leveraging decades of patient data. This ensures personalized and effective care for each individual, significantly improvingpatient outcomes and quality of life. By closely collaborating with physicians, we create impactful tests that address critical unmet clinical needs, opening a new era in cancer care.
Catapult Ventures VC Fund · Leicester, Leicester, United Kingdom
The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Funding Round, Seed, Series A
  • United Kingdom, United States, Israel
Portfolio highlights
  • CroBio — Crobio presents an environmentally sustainable solution for reducing global water consumption and preventing agricultural drought.
  • QV Bioelectronics — Manchester-based start-up QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumours.
  • Pencil Biosciences — Next Generation Genome Editing Tool
Enterprise Ireland VC Fund · Dublin, Dublin, Ireland · 21 investments in the past 12 months
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Funding Round, Seed, Series A
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Imvizar — Imvizar focuses on life-size, location-based experiences that allow users to feel as if they've gone back in time, meeting renowned individuals and witnessing historical events all from the comfort of their own phone. Imvizar was founded by Michael Guerin and is located in Dublin, Ireland.
  • Contenseo — Contenseo is a copyright exchange platform that allows copyright holders and individuals looking to reuse their work to simply connect and license their property.
  • Tao Climate — Carbon removal services. We use hemp, sustainable housing, and nextgen MRV to deliver fast, measurable impacts on climate and society.
Oxford Capital VC Fund · Oxford, Oxfordshire, United Kingdom · 5 investments in the past 12 months
Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Funding Round, Seed, Series A
  • United Kingdom, United States, France
Portfolio highlights
  • Ittybit — Ittybit is a API that enables users to handle rich media in applications. It provides developers with basic techniques for uploading, storing, transforming, and extracting data from video, music, and image files.
  • HealthKey — HealthKey is a platform that connects employers and insurers with health providers.
  • Noggin HQ — The next generation of credit referencing is coming. Look busy.
Jonathan Milner Angel · Cambridge, Massachusetts, United States · 5 investments in the past 12 months
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Series B
  • United Kingdom, United States, Canada
Portfolio highlights
  • PhoreMost — PhoreMost is a new-model drug discovery company based in Cambridge, UK: Using its core expertise to open up new ‘druggable’ target space and working with a global network of co-invested academic and industrial collaboration partners, we aim to bring a wide array of novel ‘targeted’ therapies more efficiently to market and pass these cost savingsonto patients.
  • Constructive Bio — Constructive is a ground-breaking method for creating wholly artificial genomes and rewriting the genetic code of living things.
  • LIfT BioSciences — LIfT BioSciences is a socially-minded Biotech start-up that develops a portfolio of potentially life-saving immuno-oncology cell therapies for different solid tumors using its innate immunity platform. Its goal is to create a Cell Bank with the potential to cure cancer, using Leukocyte Infusion Therapy.LIfT BioSciences was founded in 2016 andheadquartered in London, England.
Boehringer Ingelheim Venture Fund VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 3 investments in the past 12 months
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Germany, Belgium
Portfolio highlights
  • Actym Therapeutics, Inc. — Actym Therapeutics is developing key biotech to help target intractable immune pathways in the tumor microenvironment.
  • Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
  • Asgard Therapeutics — Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biologicalproperties of professional antigen-presenting cells.
Seventure Partners VC Fund · Paris, Ile-de-France, France · 6 investments in the past 12 months
Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with€ 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Series A, Series B, Funding Round
  • France, United States, Germany
Portfolio highlights
  • ID5 — ID5 provides a comprehensive suite of identification services designed to improve to improve addressability and measurement across all environments
  • Microbiotica — Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and invivo models.
  • Sequentia Biotech — Sequentia Biotech is a bioinformatics company that offers services for healthcare, pharma, agriculture, industry and environment.
Oxford Science Enterprises VC Fund · Oxford, Oxfordshire, United Kingdom · 4 investments in the past 12 months
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Series A, Seed, Series B
  • United Kingdom, United States, The Netherlands
Portfolio highlights
  • Theolytics — Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing aninternal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
  • Oxford Endovascular — Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel.This diverts the blood away from the aneurysm, allowing it to heal.
  • Grey Wolf Therapeutics — By targeting the ERAP proteases in the antigen presentation pathway Grey Wolf aims to change the antigen repertoire in cancer.
GO CAPITAL VC Fund · Rennes, Bretagne, France · 7 investments in the past 12 months
GO CAPITAL is a management company approved by the AMF and a member of AFIC. It is based in Rennes, and manages more than 130 million of assets by investing primarily in western France in innovative companies with high growth potential.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Funding Round, Seed, Series A
  • France, Canada, Israel
Portfolio highlights
  • BIOPHTA — BIOPHTA has pioneered a new approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery. Their non-invasive topical ocular inserts represent a significant advancement in the treatment of many ophthalmic disorders, providing superior long-term disease management.
  • Brightflow — Brightflow operates as a medical device startup.
  • Dealt — Dealt - La solution servicielle qui transforme votre activité retail et e-commerce
Montage, installation, configuration, entretien ou réparation… Dealt construit, implémente et gère votre offre de services en marque blanche, pour vous permettre de mieux accompagner vos clients et vous démarquer de la concurrence.Pour cela, Dealt met àdisposition des distributeurs une solution omnicanale complète, comprenant : - Les outils technologiques pour implémenter leur offre de services en marque blanche : plateforme de services, API, solution vendeur et back-office - Un catalogue de +300 services à tarifs négociés - Une communauté nationale de 10 000 professionnels certifiés - Un accompagnement total pour développer leur stratégie serviciellePassez d’un modèle de vendeur de produits à vendeur de solutions avec Dealt !Pourquoi adopter Dealt ? * +300 services disponibles * +10 000 Experts professionnels certifiés * +40 000 prestations réalisées * 4,86/5 de note moyenne * 94% de couverture nationaleCes enseignes nous font confiance : E.Leclerc, Mr. Bricolage, Botanic, Conforama, Monoprix, Casino, La Poste, Carmila…Dealt récompensé par l’écosystème retail français :- Lauréat des Trophées de l’Innovation E.Leclerc 2021, catégorie « Innovation Expérientielle »- Lauréat des Trophées 100% Retailtech LSA 2021, catégorie « Digitalisation du point de vente, expérience client et solution de paiement » - Elu start-up de l’année 2021 lors de l’événement « Connect Lille »Dealt est soutenu par le Groupe La Poste
Mercia Fund Managers VC Fund · Henley In Arden, Warwickshire, United Kingdom
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed, Funding Round, Series A
  • United Kingdom, United States, Hungary
Portfolio highlights
  • Kuano — Kuano provides innovative quantum and AI solutions for drug discovery and design. It offers a discovery platform that combines target quantum mapping and AI-led chemistry to enable the faster development of better drug candidates.
  • MGISS — Independently advising on the smarter use of Geospatial data, technology and the digital transformation of field operations.
  • Workbuzz — Give your Everyday Heroes a voice with employee surveys. Our flexible and simple survey platform reaches all employees, wherever they are. Book a demo now!
Karista VC Fund · Paris, Ile-de-France, France · 5 investments in the past 12 months
Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Seed, Series A, Series B
  • France, United States, Germany
Portfolio highlights
  • 10Lines — 10Lines is developing autonomous parking lot marking robots and technological solutions to significantly increase productivity in the industry of pavement marking. Our solutions are helping striping businesses do their work much more productively with a smaller environmental footprint.
  • BforeAI — Starting from patented technology developed in years of research, BforeAi is the prediction service that looks for newly registered or morphed domains, and score their maliciousness looking at metadata and links to other bad guys.
  • Brightflow — Brightflow operates as a medical device startup.
M Ventures VC Fund · Amsterdam, Noord-Holland, The Netherlands · 14 investments in the past 12 months
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Switzerland, United Kingdom
Portfolio highlights
  • Anjuna — Anjuna confidential cloud software establishes a secure enclave that isolates and encrypts applications and data in runtime, at rest, and on the network for end-to-end data protection
  • Formo — We're Formo, the future of dairy. Using micro fermentation, we create animal-free cheeses that humans love.
  • NanoSyrinx — NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We are using synthetic biology approaches to develop protein nanosyringes as a completely novel modality for intracellular delivery of protein and peptide biologic drugs.
BioInnovation Institute VC Fund · Copenhagen, Hovedstaden, Denmark · 3 investments in the past 12 months
BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup'smission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups.BioInnovation Institute was founded in 2018 and is based in Denmark.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Convertible Note, Pre-Seed, Debt Financing
  • Denmark, Germany, Switzerland
Portfolio highlights
  • NorFalk — NorFalk rethinks the way to produce surfactants: the active and stabilizing ingredients in household care and personal care consumer products.
  • ArcanaBio — ArcanaBio is developing realtime biosurveillance solutions that minimize workplace disruptions and support health & wellness
  • HHC Medical — HHC Medical is a health tech company developing targeted non-invasive drug delivery devices through electroporation to transfect a large number of cells. It was founded in 2019 and is headquartered in Hillerød, Denmark.
Epidarex Capital VC Fund · Bethesda, Maryland, United States · 3 investments in the past 12 months
Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.
Show more
Investment focus
  • Biotechnology, Therapeutics, Health Care
  • Series A, Seed, Series B
  • United Kingdom, United States, Germany
Portfolio highlights
  • Theolytics — Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing aninternal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
  • Curve Therapeutics — Curve has developed an innovative screening platform that is transforming the discovery of first-in-class therapeutics. The platform allows functional screening of diverse, genetically encoded Microcycle™ libraries against a broad range of disease-associated targets that are present in their native conformation inside a mammalian cell. Curve isdeploying this platform to build a pipeline of novel cancer drugs.
  • Enterprise Therapeutics — Enterprise Therapeutics is a drug discovery company dedicated to the researchand development of novel therapies for the treatment of respiratory diseases.In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlyingmechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
Centre for the Development of Industrial Technology (CDTI) VC Fund · Madrid, Madrid, Spain · 16 investments in the past 12 months
The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Funding Round, Seed, Grant
  • Spain, United States, France
Portfolio highlights
  • SOLATOM — SOLATOM sells solar steam to industries with thermal processes. Solatom is a solar concentrator designed for generating high temperature heat (steam, hot water or thermal oil) in industrial processesSolatom's modules are formed by rows of mirrors that track the sun , reflecting the sunlight on a vacuum tube. The fluid circulating through thetube absorbs the reflected energy producing an increase in the temperature of the fluid (up to 300 ° C ). Each module has a nominal power of 15kW thermal. When more capacity is needed, the modules are joined together, increasing the total power of the plant. The system is designed for be deployed on the rooftop, being its specific weight less than 23 kg/m 2 .
  • IENAI SPACE — IENAI SPACE develops efficient ionic-liquid electric propulsion systems and mission analysis for nano-satellites. The company provides propulsion modules customized for each particular platform and mission, from 2U to 12U, from RAAN-spacing to Earth-Moon transits or de-orbiting.Its versatile Tailored Taylor Thruster is highly scalable in specificimpulse and thrust. It is based on a novel iteration of electrospray thrusters, which boast high theoretical efficiencies for electric propulsion technologies in the low power range. In combination with its decreased form factor, meaning less propellant on-board, making this technology attractive in constrained volumes.IENAI SPACE was founded in 2019 and is headquartered in Madrid, Spain.
  • Trovant Technology — Trovant Technology specializes in the development of bio-based technologies for organic waste treatment and valorization, transforming this waste into bioenergy. They develop proprietary technology and tailor-made solutions, always keeping the market in mind. At the moment they are focusing on biogas upgrading and biomethane with UBI - BiologicalIntegral Biogas Upgrading.
MIG Capital VC Fund · München, Bayern, Germany · 4 investments in the past 12 months
Zusammen gestalten wir die Unternehmen von morgen.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Funding Round, Series B
  • Germany, France, Austria
Portfolio highlights
  • Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
  • SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
  • Innatera — Innatera is a Dutch nanotech company and an offspring of the Delft University of Technology in the Netherlands.
Development Bank of Wales VC Fund · Cardiff, Cardiff, United Kingdom · 20 investments in the past 12 months
Development Bank of Wales is formed in 2001 by the Welsh Assembly Government. Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed, Funding Round, Debt Financing
  • United Kingdom, Australia, United States
Portfolio highlights
  • PlantSea — PlantSea manufactures and develops sustainable products using seaweed and aquaculture materials. It offers bioplastics items as biodegradable alternatives. PlantSea is based in Gaerwen, England.
  • Menna — Be smarter about money and grow faster with Menna. Take control of your business finances today!
  • Awen Oncology — Delivering first-in-class therapeutics that target novel, undrugged cancer-specific factors, offering new hope for patients around the world.
Auriga Partners VC Fund · Paris, Ile-de-France, France
Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Funding Round
  • France, United States, Switzerland
Portfolio highlights
  • Patrowl — Identify and harden your External Security Posture with the leader. Let us manage time-consuming tasks and focus on remediation
  • Exeliom — Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs. Their mission is to harness the therapeutic potential of gut microbiota to enable people to lead longer and healthier lives. They are committed to developing the next generation of probiotics: innovative microbial therapies.Exeliom develops anew class of medicines called Live Biotherapeutics based on their growing understanding of the central role of the microbiota in the immune system.The company was founded in 2016 and is headquartered in Dijon, France.
  • Vade Secure — Vade is a global leader in predictive email defense, protecting 1 billion inboxes worldwide. AI-based email security for Microsoft 365.
Archangels VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 2 investments in the past 12 months
Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Funding Round, Seed, Series A
  • United Kingdom, United States
Portfolio highlights
  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • 1inhaler — 1inhaler operates as a developer of drug delivery device.
  • iGii — Integrated Graphene enable better products with a revolutionary design for manufacture process producing the world's highest quality pure 3D Graphene Foam, Gii.
Newable Private Investing VC Fund · London, England, United Kingdom
Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed, Funding Round, Series A
  • United Kingdom, United States
Portfolio highlights
  • Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
  • Weldfast — Weldfast is a manufacturer and supplier of welding consumables, abrasives, chemicals, premium gas equipment, and safety products.
  • EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
Idinvest Partners VC Fund · Paris, Ile-de-France, France
Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Series B, Series A, Funding Round
  • France, United States, Spain
Portfolio highlights
  • Corti — Corti offers a digital assistant, augmenting medics in improving patient outcomes and internal performance.
  • Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
  • Stilla Technologies — Stilla Technologies is taking digital PCR to a whole new level with a unique 6-color target detection capability
AlbionVC VC Fund · London, England, United Kingdom · 6 investments in the past 12 months
AlbionVC supports visionary founders with long-term capital and scale-up expertise. Founded in 1996, today we are partners to UK early-stage B2B software and healthcare companies. AlbionVC manages c. $1 billion of venture funds, currently invested in over 50 companies. AlbionVC is the technology investment arm of Albion Capital Group LLP, which isauthorised and regulated by the Financial Conduct Authority.
Show more
Investment focus
  • Software, Health Care, Artificial Intelligence
  • Series A, Funding Round, Seed
  • United Kingdom, United States, France
Portfolio highlights
  • tem. — In a few simple steps we can manage your renewable energy needs forever.
  • Treefera — Treefera is transforming the way the world approaches forest data and conservation, to create a clear future for the carbon market and the planet.
  • Infact Systems — Infact Systems is a company that focuses on bringing affordability and credit information into the 21st century. They facilitate the sharing of real-time, contextual data, primarily in the banking industry. Their mission is to increase responsible financial behavior by providing real-time data for modern credit. They offer integration andcustomization services for HPZone, particularly in terms of connecting with external laboratory systems. Infact Systems also provides services to help women take control of their finances.
Omnes Capital VC Fund · Paris, Ile-de-France, France · 5 investments in the past 12 months
Omnes, "Powering Entrepreneurs" is a Leading private equity firm dedicated to energy transition and innovation.
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Series A, Funding Round, Series B
  • France, Germany, United States
Portfolio highlights
  • Qantev — Qantev is the leading AI claims platform for health & life insurance, enabling insurers to automate claims operations, reduce leakage, improve loss ratios, enhance data quality, and elevate customer experience.
  • Carbyon — Carbyon is a Netherlands-based company that develops direct air capture (DAC) technologies. The company's fuels help to replace fossil hydrocarbons with electrical batteries or hydrogen (H2), alternative energy carriers that are used to store renewable electricity and make major changes to transportation facilities, energy grids, and gastransportation networks, filters CO2 from the air and supply it in a purified form to make kerosene for aircraft, enabling existing fossil industry to re-use and repurpose these storage and transport facilities for renewable hydrocarbons.
  • Unseenlabs — Unseenlabs designs and develops a spectrum surveillance payload which is designed to detect and track non-cooperative vessels wherever they happen to be in the world.
Elaia VC Fund · Paris, Ile-de-France, France · 22 investments in the past 12 months
Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Series A, Series B
  • France, United States, Spain
Portfolio highlights
  • Qantev — Qantev is the leading AI claims platform for health & life insurance, enabling insurers to automate claims operations, reduce leakage, improve loss ratios, enhance data quality, and elevate customer experience.
  • SURGAR — SURGAR provides a plug-and-play augmented reality software suite for computer-aided laparoscopic surgery.
  • Continuity — Continuity’s SaaS platform uses Open Data and AI to detect insurance contracts that are either outdated or invalid across four product lines including Professional Indemnity, Commercial Property, Construction Workers Insurance, and Directors & Officers Liability.
GM&C Life Sciences Fund VC Fund · Alderley Edge, Cheshire, United Kingdom
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Seed, Funding Round, Series A
  • United Kingdom, Italy, Germany
Portfolio highlights
  • ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
  • Flynotes — Flynotes is a digital software platform helping dentists deliver personalised patient care
  • QV Bioelectronics — Manchester-based start-up QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumours.
Future Planet Capital VC Fund · London, England, United Kingdom · 5 investments in the past 12 months
Brilliant Ideas. Brilliant People. Brilliant Minds.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Funding Round, Seed, Convertible Note
  • United Kingdom, United States, Canada
Portfolio highlights
  • 44.01 — We offer a permanent CO2 storage solution using the natural power of mineralisation
  • Wittaya Aqua — A better approach to aquaculture management
  • Armada Technologies — Armada Technologies created the world's first Passive Air Lubrication technology. This award-winning technology operates in a passive mode and allows for discrete control of system output while completely decoupling system lubrication from ship speed. In doing so, PALS can provide appropriate boundary layer aeration under every operatingstate.
Criteria Venture Tech VC Fund · Barcelona, Catalonia, Spain · 3 investments in the past 12 months
Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Pre-Seed to Series C) managing more than €300M of AUM.
Show more
Investment focus
  • Software, Biotechnology, E-Commerce
  • Seed, Funding Round, Series A
  • Spain, United States, United Kingdom
Portfolio highlights
  • Enline — Technology for Power Systems, TRANSMISSION AND DISTRIBUTION SYSTEM OPERATORS, INDUSTRY AND MINING, ENGINEERING & CONSTRUCTION, INSURANCE AND CONSULTANCY, UTILITIES & POWER GENERATION, ENLINE MONITORING SYSTEM, ENLINE DYNAMIC LINE RATING, ENLINE FAULT LOCATION, ENLINE POWER OPTIMIZATION .
  • Argilla — The labelling platform designed for modern MLOps. Label and improve your data with multiple feedback loops. Bridge the gap between training and production data. From experimentation to production, Argilla helps domain experts and data teams to build better NLP datasets in less time.
  • KIT-AR — Reduce time and costs spent fixing errors on your manufacturing shopfloor with quality assurance and augmented reality- Click in to find how!
Deepbridge Capital VC Fund · Chester, Cheshire, United Kingdom
Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Seed, Funding Round, Series A
  • United Kingdom, Australia, Singapore
Portfolio highlights
  • AI-Sight — AI-Sight is a startup that is developing an AI diabetic retinal screening system to deliver WHO-recommended diabetic eye screening services.
  • Microplate Dx — Safeguarding against the spread of antimicrobial resistance worldwide.
  • GenoMe Diagnostics — GenoME Diagnostics - We are developing a blood test for an earlier and more accurate diagnosis of ovarian cancer.GenoME Diagnostics .
IP Group VC Fund · London, England, United Kingdom · 3 investments in the past 12 months
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more
Investment focus
  • Health Care, Biotechnology, Therapeutics
  • Seed, Series A, Series B
  • United Kingdom, United States, Australia
Portfolio highlights
  • Microbiotica — Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and invivo models.
  • MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas
  • Enterprise Therapeutics — Enterprise Therapeutics is a drug discovery company dedicated to the researchand development of novel therapies for the treatment of respiratory diseases.In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlyingmechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
Forbion Capital Partners VC Fund · Naarden, Noord-Holland, The Netherlands · 13 investments in the past 12 months
Impacting the future of medicine.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, United Kingdom, The Netherlands
Portfolio highlights
  • Solasta Bio — Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.
  • Navigator Medicines — Leading the advancement of biologics for targeted immune regulation & restoration.
  • Bicycle Therapeutics — Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need.The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
Meusinvest (Noshaq) VC Fund · Liège, Liege, Belgium · 10 investments in the past 12 months
Noshaq offers financial services to help businesses develop.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Funding Round
  • Belgium, France, Germany
Portfolio highlights
  • Veoware — More coverage, shorter revisit time. Increasing target collection frequency through modular next-gen actuator technology.
  • Get Your Way — Discover the future of assisted reality with Get Your Way's aRdent smart glasses. Perfect for SMEs looking for innovative solutions to improve their business
  • Brenus Pharma — Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment.
HealthCap VC Fund · Stockholm, Stockholms Lan, Sweden
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Funding Round
  • United States, Sweden, France
Portfolio highlights
  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
  • Rampart Bioscience — Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from avariety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.
O2h Ventures VC Fund · 2 investments in the past 12 months
Focused on seeding early stage biotech therapeutics and related AI opportunities. The fund will invest in companies qualifying under EIS and covering novel...
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Seed, Series A, Pre-Seed
  • United Kingdom, Hungary
Portfolio highlights
  • Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
  • ViaNautis — Precision Solutions
  • Pencil Biosciences — Next Generation Genome Editing Tool
Octopus Ventures VC Fund · London, England, United Kingdom · 25 investments in the past 12 months
We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.
Show more
Investment focus
  • Software, Health Care, Artificial Intelligence
  • Series A, Seed, Series B
  • United Kingdom, United States, Germany
Portfolio highlights
  • Desia — Desia provides advanced AI applications for productivity, automation, and analytics for financial services.
  • NanoSyrinx — NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We are using synthetic biology approaches to develop protein nanosyringes as a completely novel modality for intracellular delivery of protein and peptide biologic drugs.
  • Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
Kelvin Capital VC Fund · Glasgow, Glasgow City, United Kingdom · 3 investments in the past 12 months
We invest venture capital in to globally ambitious companies which have the potential to deliver a significant return to our investors
Show more
Investment focus
  • Health Care, Biotechnology, Manufacturing
  • Seed, Funding Round, Series A
  • United Kingdom, United States
Portfolio highlights
  • Chromacity — Chromacity manufacture the next generation of ultrafast lasers. Discover our fixed wavelength femtosecond lasers and picosecond OPOs.
  • Ingenious Audio — Ingenious Audio is a Scottish start up designing and manufacturing audio electronics."invisible guitar cable" is a compact plug in device which turns an analogue audio product, such as an electric guitar or amplifier into a wi-fi device.This system allows wireless connection of any existing guitar and amplifier; and for the firsttime will allow the use of wireless effect pedals.As the product outputs, wi-fi users can connect seamlessly to any wi-fi enabled pc, replacing the need for expensive recording and audio effects devices and crucially allows sharing of audio across the web.
  • Sofant Technologies — Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems.
Cambridge Angels group VC Fund · Cambridge, Cambridgeshire, United Kingdom · 6 investments in the past 12 months
The Cambridge Angels are a group of high-net worth investors who have proven experience as successful entrepreneurs in internet, software, technology and bio-technology. Members invest in and mentor high quality start-up and early-stage companies in these sectors in the Cambridge (UK) area and throughout the UK.Typical funding requirements thatthe Cambridge Angels meet are in the range of £50,000 to £500,000 - although it is worth noting that several of their portfolio companies have received more than £1m in funding from their Members over several funding rounds.Their Members have been responsible for a large number of the “Cambridge Phenomenon” success stories over recent years. Therefore, in addition to providing funding for early-stage companies, the Cambridge Angels also offer start-ups the considerable benefit of a wide range of expertise, contacts and directly relevant experience in establishing and growing entrepreneurial businesses successfully.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed, Funding Round, Series A
  • United Kingdom, United States, Estonia
Portfolio highlights
  • xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
  • Qureight — Pioneering data curation to solve complex diseases
  • Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
AdBio partners VC Fund · Paris, Ile-de-France, France
AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Seed, Series A, Funding Round
  • France, Spain, Belgium
Portfolio highlights
  • Astraveus — Designing and building closed, automated, bioprocessing systems for the production of cell and gene therapies.
  • Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
  • Augustine Therapeutics — Augustine, Innovative therapies for neuromuscular and neurodegenerative diseases
TRICAPITAL VC Fund · Melrose, Scottish Borders, The, United Kingdom · 2 investments in the past 12 months
The TRICAPITAL Syndicate is a business angel cohort of entrepreneurs, CEOs and business leaders who have founded, funded and built companies
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Funding Round, Seed, Series B
  • United Kingdom, France
Portfolio highlights
  • HonuWorx — HonuWorx is a technology company providing autonomous systems aimed at lowering both expenses and the environmental impact of operating robotic systems. The company's software technology is an edge-cloud architected communications and control platform that enables geographically distributed stakeholders to see data, collaborate, supervise, andcontrol robotic systems that are beyond line-of-sight.
  • Sellmyartworks — EzelDotz - Buy and Sell Contemporary Art Online | Art Marketplace. Curated collection of Sculptures, Limited Editions and Originals.
  • Heero Technologies — Heero Technologies, the leading independent energy platform for making net zero homes a reality
KfW VC Fund · Frankfurt, Hessen, Germany
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Funding Round, Series A, Series B
  • Germany, India, Kenya
Portfolio highlights
  • Uniper — Uniper is an international energy company with about 11,000 employees. They combine a balanced portfolio of technologically advanced large-scale assets with outstanding technical and commercial expertise. Uniper is a German energy company based in Dusseldorf, North Rhine-Westphalia. It was formed by the separation of E.ON's fossil fuel assetsinto a separate company that began operating on 1 January 2016.
  • Vectoflow — Vectoflow is an innovative company developing fluid-dynamic metrology devices for fluid flow and dynamics measurement. It offers standardized and customized flow measurement technology that measures the static and total pressure, velocity, and angle of attack of a flow. These products are used in motorsport, aviation, turbine machine development,and research sectors.
  • Electrochaea — Electrochaea is commercializing a disruptive, scalable technology to convert electric power into methane, the principal component of natural gas. Using CO2 as a feedstock gas, power can be efficiently converted to renewable natural gas for power storage, for transportation fuels, or for transmission via a natural gas network. The company licensedtechnology from the University of Chicago and is led by the Nidus Partners, a St. Louis investment group specializing in renewable energy. Mich Hein, a Nidus Managing Partner, serves as CEO.Electrochaea has developed a commercially viable and disruptive solution for utility-scale energy storage, grid balancing, and carbon reuse. Their proprietary process converts low-cost and stranded electricity and carbon dioxide into pipeline-grade renewable gas for direct injection into the existing natural gas grid, a conversion process known as “power-to-gas”.
Investors by industry
Investors by country
Investors in Europe by industry